Business / Finance

RSS

Helsinn, BIAL sign exclusive distribution and licence agreement for Anamorelin

Helsinn, the Swiss Group focused on building quality cancer care, and BIAL - Portela & Ca. S.A., one of the largest Iberian pharmaceutical companies, today announce that they have entered into an agreement for the exclusive distribution and licence rights to Anamorelin in Spain, Portugal, Angola and Mozambique.

8 Sep 2015

Allergan enters into agreement to acquire Aquesys and its XEN45 program

Allergan plc, a leading global pharmaceutical company, and AqueSys, Inc. a private clinical stage medical device company focused on developing ocular implants that reduce intraocular pressure (IOP) associated with glaucoma, today announced that they have entered into an agreement under which Allergan will acquire AqueSys in an all-cash transaction.

4 Sep 2015

Cipla enters into definitive agreements to acquire two US-based companies

Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc.

4 Sep 2015

Publicis Healthcare purchases Tardis Medical

Publicis Healthcare, a part of Publicis Groupe, announced today that it has acquired Tardis Medical. Tardis Medical is a highly respected clinical and medical affairs outsourcing organization and consultancy business. The agency will be aligned with Publicis Touchpoint Solutions, part of PHCG, Inc—a leading provider of customized, omnichannel healthcare sales, service, and clinical teams.

3 Sep 2015

Acal BFi inks channel partner agreement in Europe with SynQor

Acal BFi, European leader in advanced technology solutions, have signed a channel partner agreement in Europe with SynQor to include UK, Ireland, Denmark, Sweden, Norway, Finland, Belgium, Netherlands, Luxemburg and Italy.

3 Sep 2015

Lannett enters into definitive agreement to purchase KU for $1.23 billion

Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.

3 Sep 2015

Prime Healthcare Services acquires St. Joseph Mercy Port Huron

Prime Healthcare Services, the fastest growing hospital system in the nation, announced today that it has completed the acquisition of St. Joseph Mercy Port Huron. As a result, St. Joseph Mercy Port Huron will now be known as Lake Huron Medical Center.

3 Sep 2015

Shire and Sangamo revise agreement to expedite development of ZFP Therapeutics for Huntington's disease, hemophilia A and B

Sangamo BioSciences, Inc., a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc, have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease.

2 Sep 2015

Ascletis completes US$35 million (RMB 220 million) financing

Ascletis announced today the completion of a US$35 million (RMB 220 million) financing. The investment was led by C-Bridge Capital, joined by Tasly Pharmaceutical and Singapore-based Pavilion Capital. The valuation of the Company before financing was US$300 million.

2 Sep 2015

Voalte secures $17 million in Series D funding

Voalte, the leader in healthcare communication technology, today announced a new capital infusion of $17 million by Ascension Ventures, Cerner Capital, Inc., an affiliate of Cerner Corporation, and Bedford Funding. Series D funding closed on July 27, 2015, bringing the total capital Voalte has raised to nearly $60 million in three years.

2 Sep 2015

HeartWare International signs definitive agreement to acquire Valtech

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced today that it has entered into a definitive agreement to acquire Valtech Cardio, Ltd.

2 Sep 2015

Amgen, Novartis collaborate for Alzheimer's disease and migraine programs

Amgen today announced a neuroscience collaboration with Novartis in the areas of Alzheimer's disease and migraine. The collaboration accelerates Amgen's potential entry into Alzheimer's disease by teaming up with Novartis on a differentiated and genetically validated Alzheimer's disease program directed at genetically predisposed individuals at risk of developing Alzheimer's disease.

2 Sep 2015

AccuTec Blades acquires EPC’s Industrial Blades division

AccuTec Blades, Inc. today announced the acquisition of Edgewell Personal Care Company's (EPC) Industrial Blades division. EPC announced in May 2015 its intent to discontinue its industrial blade operations in Verona, Virginia and Obregon, Mexico. Today's announcement marks the completion of the sale process.

2 Sep 2015

Nektar receives $40 million cash payment from first commercial sale of MOVENTIG (naloxegol)

Nektar Therapeutics announced today that it has received a $40 million cash payment under a license agreement with AstraZeneca. The payment was triggered by the first commercial sale of MOVENTIG (naloxegol) in Germany.

1 Sep 2015

BioLight Life Sciences Investments reports operational and financial results for Q2 2015

BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today reported operational and financial results for the second quarter ended June 30, 2015.

1 Sep 2015

Pepperl+Fuchs purchases MACTek

Pepperl+Fuchs, a world leader in process automation and applications, has acquired MACTek Corporation, a leading provider of HART protocol devices. The move is part of Pepperl+Fuchs' strategy to further extend its integrated solutions offerings and strengthen its position in the WirelessHART market.

1 Sep 2015

HealthSouth to acquire home health agency operations of CareSouth Health System

HealthSouth Corporation, a leading provider of post-acute healthcare services, today announced its Encompass Home Health operating unit ("Encompass") has entered into a definitive agreement to acquire the home health agency operations of CareSouth Health System, Inc. for a cash purchase price of $170 million.

31 Aug 2015